Every investor just wants to find the perfect stock – but finding the shares that check every box can be a challenge. The ...

Neuromodulation devices such as deep brain stimulators (DBS) and vagus nerve stimulators (VNS), offer innovative approaches ...

In everyday practice, the second type is the most important; in fact, there are different forms of epilepsies with the photoparoxysmal response as a peculiar aspect, which is often useful for the ...

with clinical features distinct from other epilepsies. ... New Tools Map Seizures, Improve Epilepsy Treatment Nov. 29, 2022 — Two new models could solve a problem that's long frustrated millions ...

with the ultimate goal of finding an eventual cure for KCNT1-related epilepsies. Amy Shore, a research scientist in Weston’s lab, finds inspiration in the connection with the foundation.

The NHS still rarely prescribes legal cannabis saying there has not been enough concrete research into the area to justify ...

Fintel reports that on May 1, 2024, Baird initiated coverage of Praxis Precision Medicines (NasdaqGS:PRAX) with a Outperform ...

The central objective of the laboratory is to dissect the basic mechanisms by which specific epilepsies (in which hyperexcitability may be genetic, lesional or other) result in specific derangements ...

They examine the methods for investigating motor cortex excitability and the electrophysiological and chemical characteristics of epilepsies which resemble movement disorders. They present a scheme ...

Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC are exploring how gene variants identified in children with severe epilepsy can have an impact on neurons, leading to ...

Fintel reports that on April 29, 2024, HC Wainwright & Co. initiated coverage of Ovid Therapeutics ( NasdaqGS:OVID) with a Buy recommendation.

ASX stock Little Green Pharma expects Aussie firms to share the benefits of “the most significant change in global cannabis ...